Clinical trial

Coated VICRYL* Plus Suture Compared to Chinese Silk in Scheduled Breast Cancer Surgery

NCT00768222

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention silk suture Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention VICRYL* Plus suture Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Coated VICRYL* Plus Suture Compared to Chinese Silk in Scheduled Breast Cancer Surgery

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-10-01

PhasePHASE4

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

silk sutureDEVICE

VICRYL* Plus sutureDEVICE

Sponsors & collaborators

Ethicon, Inc.lead sponsor

Johnson & Johnson Medical, Chinacollaborator

Mapped research locations

ShanghaiChina2 BeijingChina1 GuangzhouChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00768222 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.